Business Context and Reporting Period
Company: Organogenesis Holdings Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: August 9, 2022
Reporting Period: Fiscal Second Quarter ended June 30, 2022
This filing serves to announce the Company's results of operations and financial condition for the specified quarter via a press release incorporated by reference as Exhibit 99.1.
Key Financial Metrics
The provided text is a cover sheet for the Form 8-K and does not contain specific financial data points. The filing references a press release (Exhibit 99.1) for detailed figures.
- Revenue: Not provided in this text.
- Profit/Loss: Not provided in this text.
- Cash Flow: Not provided in this text.
- Margins: Not provided in this text.
- Debt and Liquidity: Not provided in this text.
Material Changes
The filing text does not provide specific comparative data or material changes versus the prior period. It only confirms the announcement of Q2 2022 results.
Guidance, Outlook, and Risks
Management Commentary: The filing states that results were announced via press release on August 9, 2022.
Legal Status of Information: The information in the attached press release is furnished and not deemed "filed" for purposes of Section 18 of the Exchange Act, nor is it incorporated by reference in other filings except as expressly set forth.
Guidance and Risks: No specific guidance, outlook, or risk factors are detailed in the provided text.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated August 9, 2022) for actual revenue, net income, and cash flow figures.
- Verify the specific details of the "Results of Operations" referenced in Item 2.02.
- Confirm whether the press release contains updated forward-looking guidance or risk factors not present in this cover sheet.